National Brain Tumor Society meets the 20 Standards for Charity Accountability.
-
Year, State Incorporated
1989, MA
-
-
-
Stated Purpose
"to invest, mobilize, and unite our community to discover a cure, deliver effective treatments, and advocate for patients and care partners."
National Brain Tumor Society (NBTS) reports that it is committed to finding better treatments, and ultimately a cure, for people living with a brain tumor. The organization states that it is able to advance its mission through funding medical research and patient care, and by informing patients and their care partners about treatment and health care. In 2019, NBTS reports that it funded $2.3 million in research grants, brought together more than 50,000 people at regional events, and had over 300 participants attend the organization's advocacy day on Capitol Hill.
For the year ended December 31, 2019, National Brain Tumor Society's program expenses were:
Program services |
$8,258,836 |
Total Program Expenses: |
$8,258,836 |
-
Chief Executive
David F. Arons, JD, Chief Executive Officer
-
Compensation*
$258,867
-
Chair of the Board
Thomas Roloff
-
Chair's Profession / Business Affiliation
Senior Vice President of Information Technology and Business Transformation, Dell Technologies Corporation
-
Board Size
16
-
Paid Staff Size
35
*2019 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Membership appeals, Planned giving arrangements, Print advertisements (newspapers, magazines, etc.), Telephone appeals, Cause- related marketing (affinity credit cards, consumer product sales, etc.)
Fundraising costs were 8% of related contributions. (Related contributions, which totaled $14,233,869 are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on National Brain Tumor Society's audited financial statements - consolidated for the year ended December 31, 2019.
Source of Funds |
Fundraising and special events |
$8,438,324 |
Grants and contributions |
$5,266,897 |
Bequests |
$250,000 |
Donated goods and services |
$221,747 |
Endowment contributions |
$56,901 |
Interest, dividends and other |
$33,770 |
Gain on investments, net |
$3,223 |
Total Income |
$14,270,862 |
- Programs: 85%
- Fundraising: 12%
- Administrative: 3%
Total Income |
$14,270,862 |
Program expenses |
$8,258,836 |
Fundraising expenses |
$1,111,468 |
Administrative expenses |
$371,194 |
Other expenses |
$0 |
Total expenses: |
$9,741,498 |
Income in Excess of Expenses |
$4,529,364 |
Beginning Net Assets |
$2,234,936 |
Other Changes In Net Assets |
$0 |
Ending Net Assets |
$6,764,300 |
Total Liabilities |
$1,023,668 |
Total Assets |
$7,787,968 |
Note: According to the organization's audited financial statements - consolidated - for the year ended December 31, 2019, NBTS received in-kind gifts totaling $221,747 in the form of donated goods and other ($116,023) and donated services ($105,724).